CL2013003596A1 - Metodo para la purificacion de anticuerpos a partir de una mezcla de proteínas producidas en un biorreactor que comprende una cromatografia de intercambio iónico; unidad operativa que puede usarse con el metodo antes indicado. - Google Patents
Metodo para la purificacion de anticuerpos a partir de una mezcla de proteínas producidas en un biorreactor que comprende una cromatografia de intercambio iónico; unidad operativa que puede usarse con el metodo antes indicado.Info
- Publication number
- CL2013003596A1 CL2013003596A1 CL2013003596A CL2013003596A CL2013003596A1 CL 2013003596 A1 CL2013003596 A1 CL 2013003596A1 CL 2013003596 A CL2013003596 A CL 2013003596A CL 2013003596 A CL2013003596 A CL 2013003596A CL 2013003596 A1 CL2013003596 A1 CL 2013003596A1
- Authority
- CL
- Chile
- Prior art keywords
- bioreactor
- antibodies
- purification
- mixture
- ion exchange
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11170239 | 2011-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013003596A1 true CL2013003596A1 (es) | 2014-06-06 |
Family
ID=45406929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013003596A CL2013003596A1 (es) | 2011-06-16 | 2013-12-16 | Metodo para la purificacion de anticuerpos a partir de una mezcla de proteínas producidas en un biorreactor que comprende una cromatografia de intercambio iónico; unidad operativa que puede usarse con el metodo antes indicado. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140187749A1 (es) |
EP (1) | EP2721052A1 (es) |
JP (1) | JP2014529330A (es) |
KR (1) | KR20140033126A (es) |
CN (1) | CN103619868A (es) |
AR (1) | AR086938A1 (es) |
AU (1) | AU2012269240B2 (es) |
BR (1) | BR112013031906A2 (es) |
CA (1) | CA2838476A1 (es) |
CL (1) | CL2013003596A1 (es) |
EA (1) | EA201400024A1 (es) |
IL (1) | IL229763A0 (es) |
MX (1) | MX2013014615A (es) |
WO (1) | WO2012171853A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9994609B2 (en) | 2013-03-15 | 2018-06-12 | Biogen Ma Inc. | Hydrophobic interaction protein chromatography under no-salt conditions |
KR102140531B1 (ko) * | 2018-08-07 | 2020-08-04 | (주)휴온스 | Gly-Tβ4의 제조방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2272870T3 (da) * | 1998-06-09 | 2013-08-05 | Csl Behring Ag | Fremgangsmåde til fremstilling af immunoglobuliner med henblik på intravenøs indgivelse og andre immunoglobulin-lignende produkter. |
WO2005044856A2 (en) | 2003-10-27 | 2005-05-19 | Wyeth | Removal of high molecular weight aggregates using hydroxyapatite chromatography |
DE10355251A1 (de) * | 2003-11-26 | 2005-06-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung enthaltend einen Antikörper gegen den EGF-Rezeptor |
NZ548126A (en) | 2004-02-27 | 2009-10-30 | Ge Healthcare Bio Sciences Ab | A process for the purification of antibodies involving addition of a second resin |
US20110257378A1 (en) | 2008-11-25 | 2011-10-20 | Ge Healthcare Bio-Sciences Ab | Aqueous two phase extraction augmented precipitation process for purification of therapeutic proteins |
JP5791602B2 (ja) * | 2009-08-07 | 2015-10-07 | イー・エム・デイー・ミリポア・コーポレイシヨン | 試料中の1つ以上の不純物から標的タンパク質を精製するための方法 |
US9527010B2 (en) * | 2009-09-25 | 2016-12-27 | Ge Healthcare Bio-Sciences Corp. | Separation system and method |
-
2012
- 2012-06-08 EP EP12729090.6A patent/EP2721052A1/en not_active Withdrawn
- 2012-06-08 CN CN201280029638.7A patent/CN103619868A/zh active Pending
- 2012-06-08 WO PCT/EP2012/060885 patent/WO2012171853A1/en active Application Filing
- 2012-06-08 EA EA201400024A patent/EA201400024A1/ru unknown
- 2012-06-08 AU AU2012269240A patent/AU2012269240B2/en not_active Expired - Fee Related
- 2012-06-08 MX MX2013014615A patent/MX2013014615A/es unknown
- 2012-06-08 BR BR112013031906A patent/BR112013031906A2/pt not_active IP Right Cessation
- 2012-06-08 US US14/126,677 patent/US20140187749A1/en not_active Abandoned
- 2012-06-08 CA CA2838476A patent/CA2838476A1/en not_active Abandoned
- 2012-06-08 KR KR1020137033190A patent/KR20140033126A/ko not_active Application Discontinuation
- 2012-06-08 JP JP2014515142A patent/JP2014529330A/ja not_active Withdrawn
- 2012-06-14 AR ARP120102118A patent/AR086938A1/es unknown
-
2013
- 2013-12-02 IL IL229763A patent/IL229763A0/en unknown
- 2013-12-16 CL CL2013003596A patent/CL2013003596A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20140187749A1 (en) | 2014-07-03 |
AR086938A1 (es) | 2014-02-05 |
JP2014529330A (ja) | 2014-11-06 |
IL229763A0 (en) | 2014-01-30 |
CN103619868A (zh) | 2014-03-05 |
EP2721052A1 (en) | 2014-04-23 |
AU2012269240A1 (en) | 2013-05-02 |
KR20140033126A (ko) | 2014-03-17 |
EA201400024A1 (ru) | 2014-04-30 |
AU2012269240B2 (en) | 2016-01-21 |
BR112013031906A2 (pt) | 2016-12-13 |
MX2013014615A (es) | 2014-02-17 |
CA2838476A1 (en) | 2012-12-20 |
WO2012171853A1 (en) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2014000183A1 (es) | Formulación farmacéutica que contienen anticuerpos anti-pcsk9; metodo para preparar dicha formulación. | |
CL2013003031A1 (es) | Metodo para estratificacion a base de bcma en pacientes con mieloma multiple; anticuerpo anti-bcma. | |
CL2012002125A1 (es) | Metodo para la purificacion de anticuerpos de una mezcla de proteina en un biorreactor; unidad operacional que se utiliza en el metodo antes descrito. | |
CL2013003792A1 (es) | Metodo para detener el crecimiento celular en un cultivo celular de mamíferos que expresan una proteina recombinante. | |
DK3370055T3 (da) | Frem- og tilbagegående mikrotomdrivsystem | |
BR112014011900A2 (pt) | um método de purificação de anticorpo | |
CL2014001123A1 (es) | Anticuerpos anti-il 36r; composicion farmaceutica que lo contiene; polinucleotido aislado que codifica el anticuerpo; metodo para la produccion del anticuerpo; kit de diagnostico que lo contiene. | |
CR20140169A (es) | Proteinas de union al antigeno cd27l | |
CL2014000888A1 (es) | Anticuerpos anti-htra1; acido nucleico que codifica dicho anticuerpo; célula anfitriona; metodo para producir dicho anticuerpo; uso para tratar degeneración macular. | |
CO6801647A2 (es) | Formulación para anticuerpo anti-α4β7 | |
CL2014001073A1 (es) | Anticuerpos humanizados que reconocen alfa-sinucleina ; metodo para detectar cuerpos de lewy; metodo para inhibir la agregacion de sinucleina o reducir los cuerpos de lewy. | |
CO6801648A2 (es) | Formulación para anticuerpo anti-α4β7 | |
IL232558B (en) | A method for antibody purification | |
BR112013024520A2 (pt) | método para preparar uma composição adsorvente,em, dispositivo de purificação de àgua | |
CL2013001883A1 (es) | Metodo de inmunoensayo para vitamina d; inmunoensayo para detectar vitamina 25-oh d en sangre. | |
EP2729482A4 (en) | PROCESS FOR PURIFYING FC FUSION PROTEIN | |
BR112013025749A2 (pt) | sistemas e métodos para fracionamento de vinhaça. | |
BR112014013034A2 (pt) | método para produzir um anticorpo | |
BR112013021464A2 (pt) | método para reduzir a demanda química de oxigênio recalcitrante de um líquido em um sistema de água. | |
BR112014029107A2 (pt) | método para determinar a concentração de uma espécie de polissorbato em uma mistura. | |
SMT201400145B (it) | Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico | |
EP2727930A4 (en) | PROCESS FOR CLEANING PROTEINS | |
BR112014012519A2 (pt) | método para purificar 1,3-batadieno | |
BR112013021775A2 (pt) | bactéria corineforme, e, método para produzir um l-aminoácido | |
BR112013007237A2 (pt) | ''método para produzir um anticorpo anti-ig-1r'' |